TMFX
Motley Fool Next Index ETF
TMFX tracks a market-cap-weighted index of mid- and small-cap US companies recommended by Motley Fools analysts and newsletters, excluding the 100 largest securities in the pool.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 33.5 M
ASSETS UNDER MGMT
50 bp
EXPENSES
Fund Basics
| Inception date | Dec 29, 2021 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| REDDIT INC-CL A | 1.9 % |
| WORKDAY INC-CLASS A | 1.7 % |
| CASEY'S GENERAL STORES INC | 1.6 % |
| COUPANG, INC. CLASS A | 1.5 % |
| EQT CORP | 1.5 % |
| TWILIO, INC. CLASS A | 1.4 % |
| CBOE HOLDINGS INC | 1.4 % |
| VEEVA SYSTEMS INC-CLASS A | 1.4 % |
| DEXCOM INC | 1.4 % |
| BIOGEN IDEC INC | 1.4 % |
Constituent Breakdown
| Number of holdings | 192 |
| Herfindahl-Hirschman Index | 85 |
| Wgt avg mkt cap (mns) | $16,750 |
| Large cap (>$10bn) | 70.9% |
| Mid cap ($2-10bn) | 24.5% |
| Small cap (<$2bn) | 2.3% |
| Developed mkts. | 95.7% |
| Emerging mkts. | 1.6% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 96.2 % |
 |
SOUTH KOREA | 1.5 % |
Historical Performance
Standardized Performance (as of 06/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 5.9% | 11.5% | 15.2% | 12.5% | -- | -- | -- | 3.0% |
| Dividend Yield | 0.0% | 0.1% | 0.1% | 0.1% | -- | -- | -- | 0.1% |
| Total Returns | 5.9% | 11.6% | 15.3% | 12.6% | -- | -- | -- | 3.1% | Ann. Volatility | 18.4% | 17.2% | 21.0% | 19.7% | -- | -- | -- | 23.3% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.08 | 62% |
| MSCI EAFE | 0.69 | 40% |
| MSCI Emg Mkts | 0.43 | 33% |
Liquidity Measures
| Avg. volume (000) | 5 |
| ADV traded (mns) | $0 |
| Turnover | 0.3% |
| Avg. Bid/Ask (% of price) | 0.14% |
Technical Indicators
| 30d moving avg. (EMA) | $22.51 |
| Relative strength (RSI) | 59 |
| MACD/Signal | 0.36/0.31 |
| Bollinger Bands (Upper/Lower) | $23.65/$21.55 |
| Short interest (% of AUM) | 0.4% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. TMFX |
Expenses vs. TMFX |
ALTAR Score™ vs. TMFX |
|---|---|---|---|---|
| MFVL | Motley Fool Value Factor ETF | 29.7% | 0 bp | +3.1% |
| VBK | Vanguard Small-Cap Growth ETF | 22.4% | -43 bp | -1.3% |
| IJK | iShares S&P Mid-Cap 400 Growth ETF | 22.2% | -33 bp | +1.6% |
| MDYG | State Street SPDR S&P 400 Mid Cap Growth ETF | 22.0% | -35 bp | +1.6% |
| IVOG | Vanguard S&P Mid-Cap 400 Growth ETF | 21.4% | -40 bp | +1.6% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 19.6% | -44 bp | +0.0% |
| XJH | iShares ESG Screened S&P Mid-Cap ETF | 18.9% | -38 bp | +3.3% |
| MFIG | Motley Fool Innovative Growth Factor ETF | 18.8% | 0 bp | +0.3% |
| MDY | SPDR S&P Midcap 400 ETF Trust | 18.7% | -27 bp | +3.2% |
| FLOW | Global X U.S. Cash Flow Kings 100 ETF | 18.7% | -25 bp | +8.2% |
Risk and Returns: TMFX vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 7/19/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
3.3%
ALTAR SCORE™
16th
PERCENTILE
AVOID
ETFRC RATING
There are 1,401 funds in the US Equity category with an average
ALTAR Score™ of 5.4% and a standard deviation
of 2.1%. TMFX's ALTAR Score™ is approximately -1.0 standard
deviations above the category average. This places TMFX in the 16th percentile
among funds in the category.
Sell-Side Consensus
$26.61
PRICE TARGET
+15.3%
UPSIDE